アジア太平洋地域のアシネトバクター肺炎治療薬市場は、2023年に約9,024万米ドルと評価され、2024年から2032年の予測期間にわたって7.53%を超える健全な成長率で成長すると予想されています。
アシネトバクター肺炎治療薬は、多くの抗生物質に対する耐性で知られるグラム陰性細菌であるアシネトバクター・バウマニによって引き起こされる肺炎に対処することを目的とした医薬品介入および治療戦略から構成されています。通常、治療には、感染株の感受性プロファイルに合わせた抗菌剤の配合が含まれ、関連する合併症を管理するための支持療法が補完されます。多くのアジア太平洋諸国では、急速な経済成長とインフラの発展により、医療へのアクセスと施設が改善されています。
アジア太平洋地域では、人口密度の高さ、感染制御対策の不備、抗生物質耐性などの要因により、肺炎を含むアシネトバクター感染症の発生率が上昇しています。この蔓延率の上昇により、アシネトバクター肺炎と戦うための効果的な治療薬の需要が高まっています。アジア太平洋のアシネトバクター肺炎治療薬市場は、医療インフラ開発への関心の高まりなどの要因によって牽引されています。さらに、アジア太平洋地域でアシネトバクター肺炎がもたらす複雑な課題に対処するには、医療機関、学術研究者、製薬会社、政府機関間の連携が不可欠です。さらに、抗生物質の選択肢が限られている中で、ペプチドやナノ粒子などの代替戦略が重要であり、抗菌薬耐性に対するイノベーションの必要性が強調され、アシネトバクター肺炎治療薬市場に課題をもたらしています。
アジア太平洋地域のアシネトバクター肺炎治療薬市場調査の対象となる主要国には、中国、インド、日本、韓国、オーストラリア、その他のアジア太平洋諸国が含まれます。中国は、感染率、抗菌薬耐性、医療費、インフラ拡張の増加により、主要な地域となっており、新しい抗生物質と治療戦略に焦点を当てた研究が進行中です。さらに、中国、インド、日本では、重症患者における院内肺炎や人工呼吸器関連肺炎の発生が増加しており、需要が高まっています。医療観光セクターの拡大により、診断と治療の可用性が向上しています。政府は、国内の生産能力を強化するために、外国からの投資や世界と地元の製薬会社の提携を促進し、サプライチェーンの改善と治療費の削減に取り組んでいます。一方、インドは予測期間中に最も速い成長率で成長すると予測されています。
目次
Table of Contents
Chapter 1. Asia Pacific Acinetobacter Pneumonia Therapeutics Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Asia Pacific Acinetobacter Pneumonia Therapeutics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Drug Class
2.3.2. By Route of Administration
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Acinetobacter Pneumonia Therapeutics Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Acinetobacter Pneumonia Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Acinetobacter Pneumonia Therapeutics Market Size & Forecasts by Drug Class 2022-202
5.1. Cephalosporins
5.2. Fluoroquinolone
5.3. Glycylcycline
5.4. Carbapenem
5.5. β-Lactam antibiotics
5.6. Sulbactam
5.7. Aminoglycoside
5.8. Polymyxins
5.9. Tetracycline
5.10. Sulfonamide
5.11. Others
Chapter 6. Asia Pacific Acinetobacter Pneumonia Therapeutics Market Size & Forecasts by Route of Administrtion 2022-2032
6.1. Parenteral
6.2. Oral
Chapter 7. Others Asia Pacific Acinetobacter Pneumonia Therapeutics Market Size & Forecasts by Country 202-2032
7.1. China Acinetobacter Pneumonia Therapeutics Market
7.1.1. Drug Class breakdown size & forecasts, 2022-2032
7.1.2. Route of Administration breakdown size & forecasts, 2022-2032
7.2. India Acinetobacter Pneumonia Therapeutics Market
7.3. Japan Acinetobacter Pneumonia Therapeutics Market
7.4. Australia Acinetobacter Pneumonia Therapeutics Market
7.5. South Korea Acinetobacter Pneumonia Therapeutics Market
7.6. Rest of Asia Pacific Acinetobacter Pneumonia Therapeutics Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Acepodia Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Albatroz Therapeutics Pte. Ltd.
8.3.3. Aravax
8.3.4. Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
List of Tables
TABLE 1. Asia Pacific Acinetobacter Pneumonia Therapeutics market, report scope
TABLE 2. Asia Pacific Acinetobacter Pneumonia Therapeutics market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3. Asia Pacific Acinetobacter Pneumonia Therapeutics market estimates & forecasts by Drug Class 2022-2032 (USD Million)
TABLE 4. Asia Pacific Acinetobacter Pneumonia Therapeutics market estimates & forecasts by Route of Administration 2022-2032 (USD Million)
TABLE 5. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. Asia Pacific Acinetobacter Pneumonia Therapeutics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Asia Pacific Acinetobacter Pneumonia Therapeutics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Asia Pacific Acinetobacter Pneumonia Therapeutics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Asia Pacific Acinetobacter Pneumonia Therapeutics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. Asia Pacific Acinetobacter Pneumonia Therapeutics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. China Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 16. China Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. China Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18. India Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 19. India Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20. India Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21. Japan Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 22. Japan Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 23. Japan Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24. Australia Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 25. Australia Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 26. Australia Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27. South Korea Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 28. South Korea Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 29. South Korea Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30.
TABLE 31. RoAPAC Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 32. RoAPAC Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 33. RoAPAC Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 34. List of secondary sources, used in the study of Asia Pacific Acinetobacter Pneumonia Therapeutics Market.
TABLE 35. List of primary sources, used in the study of Asia Pacific Acinetobacter Pneumonia Therapeutics Market.
TABLE 36. Years considered for the study.
TABLE 37. Exchange rates considered.
List of figures
FIG 1. Asia Pacific Acinetobacter Pneumonia Therapeutics market, research methodology
FIG 2. Asia Pacific Acinetobacter Pneumonia Therapeutics market, market estimation techniques
FIG 3. Asia Pacific market size estimates & forecast methods.
FIG 4. Asia Pacific Acinetobacter Pneumonia Therapeutics market, key trends 2023
FIG 5. Asia Pacific Acinetobacter Pneumonia Therapeutics market, growth prospects 2022-2032
FIG 6. Asia Pacific Acinetobacter Pneumonia Therapeutics market, porters 5 force model
FIG 7. Asia Pacific Acinetobacter Pneumonia Therapeutics market, pestel analysis
FIG 8. Asia Pacific Acinetobacter Pneumonia Therapeutics market, value chain analysis
FIG 9. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 10. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 11. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 12. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 13. Asia Pacific Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 14. Asia Pacific Acinetobacter Pneumonia Therapeutics market, Country snapshot 2022 & 2032
FIG 15. Asia pacific Acinetobacter Pneumonia Therapeutics market 2022 & 2032 (USD Million)
FIG 16. Asia Pacific Acinetobacter Pneumonia Therapeutics market, company market share analysis (2023)
